Clinical Guidelines. Management of adult patients with diabetes undergoing endoscopic procedures
|
|
- Kerry Griffin
- 5 years ago
- Views:
Transcription
1 Clinical Guidelines Management of adult patients with diabetes undergoing endoscopic s Document Detail Document type Clinical Guideline Management of adult Patients with diabetes Undergoing Document name Endoscopic Procedures Document location GTi Clinical Guidance Database Version 1.0 Effective from 07 April 2016 Review date 07 April 2019 Owner Gastrointestinal Medicine and Surgery (GMS) Author(s) Dr Sabina De Martino Specialty Doctor in Gastroenterology Dr Gautam Das SPR Diabetes & Endocrinology, Dr Anna Brackenridge, Consultant, Diabetes and Endocrinology. Felicity Andrews Physician associate in diabetes Pam Gilby, Diabetes specialist Nurse Hannan Derez, Diabetes Specialist Nurse Abhiti Gulati, Specialist Clinical Pharmacist Approved by, date Drugs and Therapeutic Committee, April 2016 Superseded documents Related documents GSTT Guidelines: - The Peri-operative management of diabetes mellitus medicines The Management of Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycaemic state (HHS) in Adults- Integrated Care Pathway Hypoglycaemia in Adults with Diabetes within the General Ward Settings: Diagnosis and Treatment Keywords Endoscopic s, endoscopy, diabetes, insulin, glucose, diabetes medications, metformin, anti-diabetic Relevant external law, regulation, standards Change History Date Change details, since approval Approved by DTC Reference: 16045t Review By: April 2019
2 Management of patients with diabetes undergoing endoscopic s General points:- 1. As patients need to be fasted before endoscopic s, patients with diabetes on diabetes medication will need advice regarding how to adjust it If it is not adjusted they are at high risk of becoming hypoglycaemic 2. All clinical staff working within Endoscopy Services at Guy s and St. Thomas NHS Trust should follow these guidelines to ensure patient safety and support before, during and after endoscopic s. 3. All clinical staff should be able to recognise the signs and symptoms of hypoglycaemia and hyperglycaemia. 4. Nurses must be trained and competent in the operation of the trust approved blood glucose monitor. They must also use their own bar code to operate the machine. 5. Nurses should treat hypoglycaemia, according to the trust guideline for both patients who can take oral fluids and those who are nil by mouth. Hypoglycaemia in Adults with Diabetes within the General Ward Settings: Diagnosis and Treatment 6. Nurses should know where the department s hypoglycaemia treatment box is situated, if you are unsure you must ask the nurse in charge of the endoscopy unit. 7. Nurses should document any hypoglycaemic events and treatment/management in the patients notes. 8. The diabetes registrar can be contacted if required on weekdays on bleep 1801 from 9.00 to and via switchboard from to Dietary advice for patients having bowel preparation: DTC Reference: 16045t Page 1 of 5 Review By: April 2019
3 Referral for The request form (GP or hospital referral) must state whether the patient has diabetes and the diabetes medication the patient is currently on. Procedure booking. All patients with diabetes should be booked first or second on the morning list wherever possible. Pre-admission advice (telephone or face to face) Medications: For s requiring bowel preparation see table 1 For s not requiring bowel preparation see table 2 Ensure patients have clear sugary drinks available at home and when coming to hospital to treat low blood glucose Ask patients to come to hospital with all their medications including insulin. If patient checks blood glucose advise to check it every 2 hours Patients may have clear sugary drinks up to 2 hours before the Admission to hospital Admission to endoscopy Admission of people with diabetes prior to endoscopy should be avoided unless there is a clear indication Discuss patient with diabetes registrar. Patients on insulin require 2 hourly Capillary Blood Glucose monitoring from admission to discharge Blood glucose levels should be between 4-15 mmol/l prior to the commencement of If blood glucose is below 4 mmol/l, follow hypoglycaemia guideline. If blood glucose level is above 15mmol/l contact diabetes registrar (bleep 1801) for further advice Post As a result of altering their diabetes medication, their diabetes control may not be optimal. Patients need to know that this is only temporary and will be back to usual control within hours. DTC Reference: 16045t Page 2 of 5 Review By: April 2019
4 Table 1) The Management of diabetes medication and insulin for patient having endoscopic s not requiring bowel preparation. Advise patient to alter medication as follows Class Diabetes drug Generic name The day before Morning Afternoon Biguanides Sulphonylurea DPP-IV inhibitor SGLT-2 inhibitor Meglitinide Metformin Metformin M/R Gliclazide Gliclazide M/R Glimepiride Glibenclamide Glipizide Tolbutamide Linagliptin Saxagliptin Sitagliptin Vildagliptin Alogliptin Dapagliflozin Empagliflozin Canagliflozin Repaglinide Nateglinide of. of. of. of. Glitazone Pioglitazone GLP-1 analogue Long or intermediate acting insulin Ultra long acting insulin Exenatide Liragutide Lixisenatide Dulaglutide Lantus (glargine) Levemir (detemir) Insulatard Humulin I Reduce all doses PM doses as normal PM doses as normal Tresiba (degludec) Short or rapid acting insulins (mealtime) Apidra (glulisine) Humalog (lispro) Humulin S Novorapid (aspart) Mixed insulin Humalog Mix 25 Humalog mix 50 Humulin M3 Novomix 30 Take HALF the usual dose at breakfast time even though not Normal insulin with evening meal Take HALF the usual dose with breakfast Normal insulin with evening meal Please note: multiple rows may apply For combination drugs please see table 3 for advice Be aware this list is NOT exhaustive and new drugs may come to market which are not included here. If in doubt check the most recent edition of the BNF or call medicines information on x83855 Inform patients if they have any concerns to contact their local diabetes team for further advice on management DTC Reference: 16045t Page 3 of 5 Review By: April 2019
5 Table 2) Management of diabetes medication and insulin for patient having endoscopic s requiring bowel preparation. Advise patient to alter medication as follows: Class Biguanides Sulphonylurea DPP-IV inhibitor SGLT-2 inhibitor Meglitinide Diabetes drug Generic name Metformin Metformin M/R Gliclazide Gliclazide M/R Glimepiride Glibenclamide Glipizide Tolbutamide Linagliptin Saxagliptin Sitagliptin Vildagliptin Alogliptin Dapagliflozin Empagliflozin Canagliflozin Repaglinide Nateglinide The day before Morning Afternoon OMIT all doses of. of. of. of. Glitazone Pioglitazone GLP-1 analogue Long or intermediate acting insulin Ultra long acting insulin Exenatide Liragutide Lixisenatide Dulaglutide Lantus (glargine) Levemir (detemir) Insulatard Humulin I Reduce all doses PM doses as normal PM doses as normal Tresiba (degludec) Short or rapid acting insulins (mealtime) Apidra (glulisine) Humalog (lispro) Humulin S Novorapid (aspart) Mixed insulin Humalog Mix 25 Humalog mix 50 Humulin M3 Novomix 30 Take HALF the usual dose with breakfast Take HALF the usual dose in the evening even though not HALF the usual dose at breakfast time even though not Normal insulin dose with evening meal HALF the usual dose at breakfast time even though not Normal insulin dose with evening meal Please note: multiple rows may apply For combination drugs please see table 3 for advice Be aware this list is NOT exhaustive and new drugs may come to market which are not included here. If in doubt check the most recent edition of the BNF or call medicines information on x83855 Inform patients if they have any concerns to contact their local diabetes team for further advice on management DTC Reference: 16045t Page 4 of 5 Review By: April 2019
6 Table 3) Combination anti-diabetic medications Please use the table below and then refer back to table 1 and table 2 to adjust combination antidiabetic medication. Generic name Brand name(s) Advice Alogliptin AND Metformin Vipdomet Treat as DPP IV inhibitor Linagliptin AND Metformin Jentadueto Treat as DPP IV inhibitor Saxaglptin AND metformin Komboglyze Treat as DPP IV inhibitor Sitagliptin AND metformin Janumet Treat as DPP-IV inhibitor Vildagliptin AND metformin Eucreas Treat as DPP-IV inhibitor Canagliflozin AND Metformin Vokanamet Treat as SGLT2 inhibitors Dapagliflozin AND Metformin Xigduo Treat as SGLT2 inhibitors Empagliflozin and Metformin Synjardy Treat as SGLT2 inhibitors Pioglitazone AND metformin Competact Treat as glitazone Liraglutide AND Insulin Degludec Xultophy Treat as long-acting insulin DTC Reference: 16045t Page 5 of 5 Review By: April 2019
Information for Patients
Information for Patients Guidance for Diabetic Persons having an OGD or Bronchoscopy This guidance is provided to assist with your preparation for your endoscopic procedure. If you feel unclear about how
More informationFasted and Consented but Blood Glucose 18mmol/L or How to Manage Diabetes in the Peri-Operative Period
Fasted and Consented but Blood Glucose 18mmol/L or How to Manage Diabetes in the Peri-Operative Period Dr Ketan Dhatariya MBBS MSc MD MS FRCP Consultant in Diabetes and Endocrinology Norfolk and Norwich
More informationPeri-operative management of the surgical patient with diabetes GL059
DT Peri-operative management of the surgical patient with diabetes GL059 Approval Approval Group Job Title, Chair of Committee Date Anaesthetics Clinical Governance Chair Anaesthetic governance Nov 2016
More informationUpdated August /08/2020
Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Directorate & Speciality Guideline for the management of adults with diabetes
More informationPERIOPERATIVE DIABETES GUIDELINE
PERIOPERATIVE DIABETES GUIDELINE This Guideline does not replace the need for the application of clinical judgment in respect to each individual patient. Background Diabetes mellitus is estimated to affect
More informationWhat the Pill Looks Like. How it Works. Slows carbohydrate absorption. Reduces amount of sugar made by the liver. Increases release of insulin
Diabetes s Oral s - Pills These are some of the pills that are currently available in Canada to treat diabetes. Each medication has benefits and side effects you should be aware of. Your diabetes team
More informationTABLE 1A: Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations
177 TABLE 1A: Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations TABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations Formulary
More information3. Cardiovascular Disease?
Swiss recommendations 2016 Swiss Society of Endocrinology and Diabetology 1. Deficiency? Basal Premixed- Basal + GLP-1 RA (Xultophy ) or Basal Bolus 2. egfr < 30 ml/min? 3. Cardiovascular Disease? 4. Heart
More informationTABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations
177 TABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations Formulary Coverage Indication for use with: INSULIN THERAPY NS NB NL PE ADULTS PEDIATRICS PREGNANCY BOLUS
More informationTitle Peri-operative Guidelines for the Management of Patients with Diabetes. Author s job title Diabetes Specialist Nurse Department.
Patients with Document Control Title Peri-operative Guidelines for the Management of Patients with Author Directorate Medicine Version Date Issued 0.1 Jan 2011 Status Draft Initial version Author s job
More informationObjectives. How Medicine Works to Control Blood Sugar Levels. What Happens When We Eat? What is diabetes? High Blood Glucose (Hyperglycemia)
How Medicine Works to Control Blood Sugar Levels Stacie Petersen, RN, CDE Objectives Define Diabetes List how medications work (ominous octet) Identify side effects of medications for diabetes What is
More informationManagement of Adults with Diabetes Undergoing Surgery and Elective Procedures Guidelines. Diabetes Inpatient Steering Group June 2016
Management of Adults with Diabetes Undergoing Surgery and Elective Procedures Guidelines Diabetes Inpatient Steering Group June 2016 1. Introduction 1.1 The aim of the guideline is to improve standards
More informationGlucose Control drug treatments
Glucose Control drug treatments It should be noted that glitazones are under suspicion of precipitating acute cardiac events and current recommendations contraindicate the use of glitazones in patients
More informationHow can we improve outcomes in Type 2 diabetes?
How can we improve outcomes in Type 2 diabetes? Earlier diagnosis Better patient education Stress central role of lifestyle management Identify and treat all risk factors Use rational pharmacological therapy
More informationDIABETES (1 of 5) Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10. Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10 $0 $0 $0
Metformin DIABETES (1 of 5) Glucophage Glucophage XR ER $7 (500mg) $7 (500mg) $5 $5 500mg, 750mg only 500mg, 750mg only Sulfonylurea/Combinations Amaryl Glucotrol glimepiride glipizide $5 $5 Glucotrol
More informationDIABETES INDICATIONS FOR INSULIN
DIABETES INDICATIONS FOR INSULIN 1 Introduce the likely need for insulin in the future early on as part of patient education Emphasise that it is the pancreas that fails not the patient Assess if greater
More informationThere have been important changes in diabetes care which may not be covered in undergraduate textbooks.
Diabetes Clinical update There have been important changes in diabetes care which may not be covered in undergraduate textbooks. Changes in the diagnosis of diabetes a) HbA1C Since 2011, World Health Organisation
More informationDept of Diabetes Main Desk
Dept of Diabetes Main Desk 01202 448060 Glucose management in Type 2 Diabetes in Adults The natural history of type 2 diabetes is for HbA1c to deteriorate with time. A stepwise approach to treatment is
More informationTable 1. Antihyperglycemic agents for use in type 2 diabetes
Table 1. Antihyperglycemic agents for use in type 2 diabetes DRUG IN ALPHA-GLUCOSIDASE INHIBITOR: inhibits pancreatic alpha-amyle and intestinal alpha-glucoside Acarbose (Glucobay) 0.6% Negligible Not
More informationHow they work and when to take them. Diabetes Medications
How they work and when to take them Diabetes Medications BIGUANIDES Metformin Actions Slows down the release of glucose from the liver. Helps the bodies cells become more sensitive to insulin. Pros Weight
More informationDiabetes, Type 2 Management
CLINICAL GUIDELINE Diabetes, Type 2 Management A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments. Clinical judgement should be exercised on the applicability
More informationManaging diabetes if you are having a colonoscopy
Managing diabetes if you are having a colonoscopy Diabetes and Endocrinology Patient Information Leaflet Introduction This leaflet provides advice and instructions to people with diabetes who are going
More informationYOU HAVE DIABETES. Angie O Connor Community Diabetes Nurse Specialist 25th September 2013
YOU HAVE DIABETES Angie O Connor Community Diabetes Nurse Specialist 25th September 2013 Predicated 2015 figures are already met 1 in 20 have diabetes:1in8 over 60years old Definite Diagnosis is key Early
More informationEndoscopy or colonoscopy guidelines
Endoscopy or colonoscopy guidelines for patients with diabetes The development and audit of local pilot guidelines for patients with diabetes undergoing an endoscopy or colonoscopy as an out-patient D
More informationSearch strategies key terms
Online Resource - Search strategies key terms - Table S1a,b: characteristics RCTs comparing GLP-1 with insulin - Table S2a,b: characteristics observational studies comparing DPP-4i with sulfonylurea -
More informationObjectives. Recognize all available medical treatment options for diabetes. Individualize treatment and glycemic target based on patient factors
No disclosure Objectives Recognize all available medical treatment options for diabetes Individualize treatment and glycemic target based on patient factors Should be able to switch to more affordable
More informationSTEP THERAPY CRITERIA
CATEGORY DRUG CLASS BRAND NAME (generic) STEP THERAPY CRITERIA AMYLIN ANALOG: SYMLIN/SYMLINPEN (pramlintide acetate) ANTIDIABETIC AGENTS GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST (GLP-1): ADLYXIN (lixisenatide)
More informationPLEASE CHECK FULL SPECIFIC PRODUCT CHARACTERISTICS FOR MORE DETAILED AND CURRENT INFORMATION:
Metformin Standard tablets Modified-release tablets Metformin 1g sachets Metformin liquid 500mg/5ml (avoid use as expensive) < 2.00 5.32 for 56 tabs 500mg 13.16 for 60 sachets > 120 Ketoacidosis General
More informationManagement of Type 2 Diabetes Mellitus. Heather Corn, MD, MS Endocrinology, Diabetes, and Metabolism
Management of Type 2 Diabetes Mellitus Heather Corn, MD, MS Endocrinology, Diabetes, and Metabolism Disclosures Working for Intermountain Healthcare Some of the views represented are the opinion of ABIM-certified
More informationInpatient Diabetes 20/01/2015. What should I do? Hyperglycaemia why does it matter? Why are the BSLs unstable? BSL parameters
Hyperglycaemia why does it matter? Inpatient Diabetes Angela Sheu Endocrine Registrar St George Hospital Hyperglycaemia at admission is a predictor of mortality May be part of stress response (eg post
More informationPharmacology Updates. Quang T Nguyen, FACP, FACE, FTOS 11/18/17
Pharmacology Updates Quang T Nguyen, FACP, FACE, FTOS 11/18/17 14 Classes of Drugs Available for the Treatment of Type 2 DM in the USA ### Class A1c Reduction Hypoglycemia Weight Change Dosing (times/day)
More informationInsulin Therapies: An Educational Toolkit
University Hospitals of Leicester, Department of Diabetes and Leicester Diabetes Centre: Insulin Therapies: An Educational Toolkit This document is designed for use by those trained and competent in insulin
More informationSTEP 3: Add or Substitute with one of
Prescribing of Hypoglycaemic Agents for Adult Patients with Type 2 Diabetes: Sunderland Refer to DESMOND Structured Education classes to promote Increased Physical Activity, Weight Loss and Calories Reduction
More informationSociety for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery
Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery Girish P. Joshi, MB BS, MD, FFARCSI Anesthesia & Analgesia
More information1/15/2018. Disclosures. Current Diabetes Medications. Objectives NON-INSULIN AGENTS. Diabetes Med Classes. Mealtime
Disclosures Current Diabetes Medications None Claire Baker, M.D. Diabetes & Endocrine Associates January 24, 2018 Objectives Identify categories of diabetes medications Understand the pharmacology of diabetes
More informationManaging Hyperglycaemia in Acute (Adult) Inpatients Requiring Enteral Feeding Guidelines
Document Control Title Managing Hyperglycaemia in Acute (Adult) Inpatients Requiring Author Author s job title Specialist Nurse Consultant Physician Department Directorate Unscheduled Care Version Date
More informationThe principles of insulin adjustment guidance
The principles of insulin adjustment guidance Tips for insulin titration Blood glucose (BG) monitoring is needed to help identify the efficacy of treatment in diabetes. Monitor blood glucose according
More informationTHIS IS A PATIENT HAND HELD DOCUMENT CARE PATHWAY FOR MANAGEMENT OF INITIATION OF INSULIN
Worcestershire Trusts Please attach patient sticker here or record: GP Name: Consultant:. Ward: THIS IS A PATIENT HAND HELD DOCUMENT CARE PATHWAY FOR MANAGEMENT OF INITIATION OF INSULIN This Care Pathway
More informationClinical Cases in Diabetes Management. Joseph Cook D.O.
Clinical Cases in Diabetes Management Joseph Cook D.O. Objectives State the prevalence of Diabetes Mellitus in Ohio State the percentage of diabetic patients in the U.S. treated by Primary Care Physicians
More informationFeidhmeannacht na Seirbhíse Sláinte
Feidhmeannacht na Seirbhíse Sláinte Health Service Executive Feidhmeannacht na Seirbhíse Sláinte Seirbhís Aisíocaíochta Cúraim Phríomhúil Bealach amach 5 an M50 An Bóthar Thuaidh Fionnghlas Baile Átha
More information667FM.5.1 MANAGEMENT OF TYPE 2 DIABETES: BLOOD-GLUCOSE-LOWERING THERAPY
667FM.5.1 MANAGEMENT OF TYPE 2 DIABETES: BLOOD-GLUCOSE-LOWERING THERAPY Contents Introduction... 1 Patient Education for People with Type 2 Diabetes... 2 Dietary Advice for People with Type 2 Diabetes...
More informationPhysiology of Normoglycemia
Case 1 45 year-old male patient seen at the clinic (Medicine). Workplace stress (financial analyst); occasionally goes jogging. Two-year duration of T2DM. No previous cardiovascular events. Coexisting
More informationPhysician Drug Reference Chart for Diabetes Antidiabetic Medications
Drug Class Compound Brand Name Mechanism of Action Advantages Disadvantages Alpha-glucosidase inhibitors Medium Cost by Bayer Healthcare, Pfizer, Takeda Research Acarbose Miglitol Voglibose Precose Glyset
More informationShort-acting insulins. Biphasic insulins. Intermediate- and long-acting insulins
Recommended Insulin Products This guideline states the Gloucestershire Joint Formulary recommended, first choice insulin products. The intention is to support the choice of treatment for new patients,
More informationDiabetes Treatment Guidelines
Diabetes Treatment Guidelines For more comprehensive information about current approaches to the diagnosis and treatment of diabetes, visit the American Diabetes Association Standards of Medical Care 2018
More informationInjectable Therapies in Diabetes
Injectable Therapies in Diabetes Diabetes Specialist Nurse Linda Burns Learning Outcomes Understand the place of injectible therapies in diabetes Understand when patients may require insulin therapy Consider
More informationTREATMENTS FOR TYPE 2 DIABETES. Susan Henry Diabetes Specialist Nurse
TREATMENTS FOR TYPE 2 DIABETES Susan Henry Diabetes Specialist Nurse How can we improve outcomes in Type 2 diabetes? Earlier diagnosis Better patient education Stress central role of lifestyle management
More informationCollaborative Practice Agreement
Collaborative Practice Agreement [community pharmacy name] [address] [phone number] [physician practice] [address] [phone number] Effective: [date] Expiration: [date] 1 Table of Contents 1.0 Introduction...4
More informationDiabetes Management (Adults and Young People) Ref CLIN-0081.v2.2. Status: Ratified Document type: Guideline
Diabetes Management (Adults and Young People) Ref CLIN-0081.v2.2 Status: Ratified Document type: Guideline Contents 1 Purpose... 4 2 Related documents... 4 3 Introduction... 5 3.1 Definition... 5 3.2 Prevalence
More informationRPCC Pharmacy Forum. The Type 2 Diabetes Issue. Type 2 Diabetes: The Basics
Nov/Dec 2015 Issue 11 RPCC Pharmacy Forum Special Interest Articles: Diabetes Medication Chart Insulin Chart Afreeza Did you know? Exanatide, marketed as Byetta, is the synthetic form of exendin-4, which
More informationDrug Therapy for Diabetes Mellitus. Adj A/Prof Daniel Chew Dept of Endocrinology 8 th July 2017
Drug Therapy for Diabetes Mellitus Adj A/Prof Daniel Chew Dept of Endocrinology 8 th July 2017 Diabetes Subtypes Optimal Treatment Ominous Octet DeFronzo. DIABETES, VOL. 58, APRIL 2009 Schematic Overview
More informationDrugs used in Diabetes. Dr Andrew Smith
Drugs used in Diabetes Dr Andrew Smith Plan Introduction Insulin Sensitising Drugs: Metformin Glitazones Insulin Secretagogues: Sulphonylureas Meglitinides Others: Acarbose Incretins Amylin Analogues Damaglifozin
More informationArrange 3 Monthly Review Re-enforce LIFESTYLE advice and check DRUG COMPLIANCE at each visit Target HbA1c < 53mmol/mol
Prescribing of Hypoglycaemic Agents for Adult Patients with Type 2 Diabetes: Sunderland Refer to DESMOND Structured Education classes to promote Increased Physical Activity, Weight Loss and Calories Reduction
More informationLeicestershire Diabetes Guidelines: Insulin Therapy
Endorsed by Leicestershire Medicines Strategy Group Leicestershire Diabetes Guidelines: Insulin Therapy These guidelines are designed for use by those trained and competent in insulin initiation and management
More informationOxford Kidney Unit. Preparing for your operation: information for people with chronic kidney disease
Oxford Kidney Unit Preparing for your operation: information for people with chronic kidney disease page 2 You have been given this booklet to help you prepare for a surgical procedure under general anaesthetic.
More informationEnd of Life Diabetes Care
End of Life Diabetes Care Commissioned by Diabetes UK Supplementary Documents and Flowcharts Endorsed By: Diabetes Phases of End of Life and Medications A - Blue: All From Diagnosis Stable With Year Plus
More informationPeri-Operative Guidelines for Management of Diabetes Patients
Peri-Operative Guidelines for Management of Diabetes Patients Target blood glucose 6-10 mmol/l for all patients Acceptable blood glucose 4-11 mmol/l for all patients Definitions Non-Insulin Glucose Lowering
More informationDiabetes Mellitus II CPG
1 Diabetes Mellitus II CPG Candidates for Screening Integrated Complex Care Patients: Check Yearly Prediabetes: Check Yearly No Diabetes Mellitus (DM) Risk Factors: Check at Age 45, Repeat Every 3 Years
More informationSt Helens & Knowsley Teaching Hospitals Adult Inpatient Diabetes Management Guidelines v24
St Helens & Knowsley Hospitals, 2014-16 Adult Inpatient Diabetes Management Guidelines St Helens & Knowsley Teaching Hospitals Adult Inpatient Diabetes Management Guidelines 2014-2016 v24 Title Adult Inpatient
More informationMANAGEMENT OF TYPE 2 DIABETES
MANAGEMENT OF TYPE 2 DIABETES 3 Month trial of lifestyle changes. Refer to DESMOND structured education programme. Set glycaemic target HbA1c < 7.0% (53mmol/mol) or individualised If HbA1c > 53mmol/mol
More informationTYPE 2 DIABETES CRITERIA FOR REFERRAL TO LEVEL 2 OOHS
TYPE 2 DIABETES CRITERIA FOR REFERRAL TO LEVEL 2 OOHS The aim of the Diabetes level 2 service is to provide a high quality service for safe initiation and optimization of injectable therapy within GP networks.
More informationManagement of adults with diabetes undergoing surgery and elective procedures: improving standards
Surgical outpatients Hospital admission Theatre and recovery Discharge Primary care referral Pre-operative assessment Post-operative care Management of adults with diabetes undergoing surgery and elective
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Single Technology Appraisal. Canagliflozin in combination therapy for treating type 2 diabetes
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Single Technology Appraisal Canagliflozin in combination therapy for Final scope Remit/appraisal objective To appraise the clinical and cost effectiveness
More informationDiabetes Update: Keeping patients safe. Victoria Ruszala MFRPSII North Bristol NHS Trust
Diabetes Update: Keeping patients safe Victoria Ruszala MFRPSII North Bristol NHS Trust Declaration of Interests I have received funding from the following companies for providing education sessions, attending
More informationDrug Class Review Monograph GPI Class 27 Anti-diabetics
Drug Class Review Monograph GPI Class 27 Anti-diabetics Review Time Frame: 11/2015 04/2017 Previous Class Review: 02/2016 Background: Antidiabetic drug classes include: Alpha-glucosidase inhibitors- slow
More informationPre admission & surgery Pre-admission Nurses Association SIG Catherine Prochilo Credentialled Diabetes Nurse Educator Sat 23 March 2013
Pre admission & surgery Pre-admission Nurses Association SIG Catherine Prochilo Credentialled Diabetes Nurse Educator Sat 23 March 2013 www.diabetesvic.org.au Plan/ overview Issue/ presenting problems
More informationGastroscopy - Oesophago-gastro duodenoscopy (OGD)
James Paget University Hospitals NHS Foundation Trust Gastroscopy - Oesophago-gastro duodenoscopy (OGD) The procedure explained. Your appointment details, information and consent form. Patient Information
More informationDIABETES. overview of pharmacologic agents used in the management of. Overview 4/3/2014 OBJECTIVES. Injectable Agents
overview of pharmacologic agents used in the management of DIABETES Kyle Roberts, Pharm.D. PGY-1 Pharmacy Resident Saint Alphonsus RMC 1. List the different classes of diabetes medications, including the
More informationPharmacologic Agents for Treatment of Type 2 Diabetes
Pharmacologic Agents for Treatment of Type 2 Diabetes SCAN Drugs Medication Biguanides 1 1 er uncoated tabs 500 mg & 750 mg Sulfonylureas 1 1 500 850 mg QD - TID 500 2000 mg glimepiride 1 1 1 8 mg glipizide
More informationImages have been removed from the PowerPoint slides in this handout due to copyright restrictions. Insulins. Rapid Short Intermediate Long Mix
Diabetes Medications Diabetes Medications Type 1 Insulin is needed Type 2 Oral Diabetes Medications Or Oral Diabetes Medications plus Insulin Or Insulin Alone Diabetes Medications Secretagogues Glipizide
More informationDiabetes Medication Updates Erica Bukovich, PharmD, BC-ADM, CDE September 20, 2018
Diabetes Medication Updates Erica Bukovich, PharmD, BC-ADM, CDE September 20, 2018 Learning Objectives Identify medication classes available for treatment of individuals with diabetes. Demonstrate understanding
More informationType 2 Diabetes: Where Do We Start with Treatment? DIABETES EDUCATION. Diabetes Mellitus: Complications and Co-Morbid Conditions
Diabetes Mellitus: Complications and Co-Morbid Conditions ADA Guidelines for Glycemic Control: 2016 Retinopathy Between 2005-2008, 28.5% of patients with diabetes 40 years and older diagnosed with diabetic
More informationType 2 diabetes in adults: controlling your blood glucose by taking a second medicine what are your options?
Patient decision aid Type 2 diabetes in adults: controlling your blood glucose by taking a second medicine what are your options? nice.org.uk/guidance/ng28 Published: December 2015 About this decision
More informationDiabetes medication pharmacology
BJA Education, 17 (6): 198 207 (2017) Matrix reference 1A02, 2A03, 3A06 doi: 10.1093/bjaed/mkw075 Advance Access Publication Date: 22 February 2017 Diabetes medication pharmacology Daniel J Stubbs BA BMBCh
More informationNHS GREATER GLASGOW AND CLYDE BOWEL SCREENING PROGRAMME. Clinical Policy Guidelines
NHS GREATER GLASGOW AND CLYDE BOWEL SCREENING PROGRAMME Clinical Policy Guidelines Management of patients with diabetes undergoing colonoscopy procedure following positive FOB test Date approved: 25 April
More informationMedical care of diabetes - what s new?
emedic research training 29 May 2012 Loimaa Medical care of diabetes - what s new? Markku Vähätalo Specialist in General Practice Special qualification for the treatment of diabetes Loimaa health centre
More information7/8/2016. Sol Jacobs MD, FACE Division of Endocrinology Emory University School of Medicine
Sol Jacobs MD, FACE Division of Endocrinology Emory University School of Medicine Participation in investigator initiated clinical research supported by: Merck Boehringer Ingelheim Novo Nordisk Astra Zeneca
More informationNorthumbria Healthcare NHS Foundation Trust. Sick Day Rules for People with Diabetes. Issued by the Diabetes Service
Northumbria Healthcare NHS Foundation Trust Sick Day Rules for People with Diabetes Issued by the Diabetes Service www.northumbria.nhs.uk Background: How illness may affect your diabetes 3 What to do for
More informationGuidelines for managing diabetes in Ramadan
Guidelines for managing diabetes in Ramadan Sarah Ali 1, Melanie J Davies 2,3, Emer M Brady 3, Laura J Gray 4,, Kamlesh Khunti 2,3, Salem A Beshyah 5, Wasim Hanif 6 1. Department of Diabetes & Endocrinology,
More informationFebruary 2016 DIABETES PHARMACY TEAMS MAKE A DIFFERENCE. Why am I here? Why are you here? Identifying people at risk. What can we do?
DIABETES PHARMACY TEAMS MAKE A DIFFERENCE Sallianne Kavanagh MRPharmS, MSc, IP Lead Pharmacist Diabetes and Endocrinology Sheffield Teaching Hospitals UKCPA Joint Chair Diabetes and Endocrinology Why am
More informationInjectable Therapies in Diabetes
Injectable Therapies in Diabetes Diabetes Specialist Nurse Joyce Robson Learning Outcomes Think about the place of injectible therapies in diabetes Think about when / why patients require insulin therapy
More informationNew Antidiabetic Medications
New Antidiabetic Medications A/Prof Harvey Newnham Director of General Medicine Clinical Program Director Emergency and Acute Medicine, Alfred Health, Melbourne 5 th May 2013 Diagnosed Diabetes USA Adults
More informationPreventing Heart Attacks and Strokes Every Day (PHASE) RCHC Medication Titration Algorithm
Preventing Heart Attacks and Strokes Every Day (PHASE) RCHC Medication Algorithm Updated 9/13/2017 PHASE Populations DM: type 2 ASCVD: hx heart attack/cad, CVA, TIA, AAA, Sx PAD Lifestyle Modifications
More informationDiabetes mellitus. Treatment
Diabetes mellitus Treatment Recommended glycemic targets for the clinical management of diabetes(ada) Fasting glycemia: 80-110 mg/dl Postprandial : 100-145 mg/dl HbA1c: < 6,5 % Total cholesterol: < 200
More informationDiabetes and Ramadan: Practical guidelines
Diabetes and Ramadan: Practical guidelines 1. Introduction Fasting during Ramadan is one of the five pillars of Islam and is obligatory for all healthy adult Muslims. The timing of Ramadan is based on
More informationCurrent and future market dynamics overview
OVERVIEW Catalyst Summary EXECUTIVE SUMMARY Strategic scoping and focus Datamonitor key findings Related reports MARKET DEFINITION Published diabetes reports Market definition for antidiabetic drugs Forecast
More informationWhat s New in Type 2 Diabetes? 2018 Diabetes Updates
What s New in Type 2 Diabetes? 2018 Diabetes Updates Gretchen Ray, PharmD, PhC, BCACP, CDE Associate Professor, UNM College of Pharmacy January 28, 2018 gray@salud.unm.edu OBJECTIVES Describe the most
More informationOral and Injectable Non-insulin Antihyperglycemic Agents
Appendix 5: Diabetes Education and Medical Management in Adults with Diabetes Oral and Injectable Non-insulin s This directive will be implemented by RPhs, RNs or RDs who have been deemed authorized implementers.
More informationGUIDELINE FOR SELF MONITORING OF BLOOD GLUCOSE IN ADULTS WITH DIABETES
It is recognised that self- monitoring of blood glucose (SMBG) may have an important role to play for some patients with. It can allow individuals to see what impact particular behaviours, such as dietary
More informationOral Agents. Ian Gallen Consultant Community Diabetologist Royal Berkshire Hospital Reading UK
Oral Agents Ian Gallen Consultant Community Diabetologist Royal Berkshire Hospital Reading UK What would your ideal diabetes drug do? Effective in lowering HbA1c No hypoglycaemia No effect on weight/ weight
More informationDiabetes Mellitus case studies. Jana Vinklerová
Diabetes Mellitus case studies Jana Vinklerová Definition of diabetes (metabolic disorder) Chronically raised blood glucose (hyperglycaemia) Insulin/Glucagon Insulin is responsible for lowering glucose
More informationInformation for all patients taking insulin who are admitted to hospital on day of surgery
Information for all patients taking insulin who are admitted to hospital on day of surgery Exceptional healthcare, personally delivered Introduction Many patients are now admitted to hospital on the day
More informationInjectable Therapies in Diabetes
Injectable Therapies in Diabetes Diabetes Specialist Nurse Joyce Robson Learning Outcomes Think about the place of injectible therapies in diabetes Insulin therapy GLP1 antagonists Consider commonly used
More informationKeep Calm and Focus on the Evidence for the Management of Diabetes. Diabetes Update 2018
Keep Calm and Focus on the Evidence for the Management of Diabetes Diabetes Update 2018 Nicole C.Pezzino, PharmD, BCACP, CDE Assistant Professor, Wilkes University Pharmacist, Weis Markets Nicole.pezzino@wilkes.edu
More informationPharmacological Glycaemic Control in Type 2 Diabetes
Pharmacological Glycaemic Control in Type 2 Diabetes Aim(s) and Objective(s) This guideline aims to offer advice on the pharmacological management for those who require measures beyond diet and exercise
More informationIntensification of Diabetic Therapy. Case studies
Intensification of Diabetic Therapy Case studies Patient #1 1 st visit: 64 year old male, H/O prediabetes, lost weight 280 lbs. to 240 lbs. ER for dental abscess, glucose >300 A1C 11.4%, no diabetic medication,
More informationAntidiabetic Agents CHAPTER BIGUANIDES
ajt/shutterstock, Inc. CHAPTER 2 Antidiabetic Agents Charles Ruchalski, PharmD, BCPS BIGUANIDES For newly diagnosed patients with type 2 diabetes, the biguanide metformin is the drug of choice for initial
More informationClinical Guideline for the management of paediatric patients with Diabetes Type 1 & 2 requiring Surgery or General Anaesthetic. V4
Clinical Guideline for the management of paediatric patients with Diabetes Type 1 & 2 requiring Surgery or General Anaesthetic. V4 Page 1 of 27 Abbreviation Meaning PDSN DKA BG SC IV RCHT HDU PEWS Paediatric
More informationManaging Complex Diabetes Cases: Medication Update. Celia Levesque MSN, RN, CNS-BC, CDE, BC-ADM
Managing Complex Diabetes Cases: Medication Update Celia Levesque MSN, RN, CNS-BC, CDE, BC-ADM clevesqu@mdanderson.org Objectives Describe how each diabetes medication class is used to treat diabetes Differentiate
More informationLiraglutide (Victoza) in combination with basal insulin for type 2 diabetes
Liraglutide (Victoza) in combination with basal insulin for type 2 diabetes May 2011 This technology summary is based on information available at the time of research and a limited literature search. It
More information